Page last updated: 2024-12-07
n-methylglycinamide
N-methylglycinamide (NMG) is a naturally occurring compound found in various organisms, including bacteria, fungi, and mammals. It is a derivative of glycine, with a methyl group attached to the nitrogen atom. NMG has been extensively studied for its biological activities and potential applications in various fields, including medicine and agriculture.
NMG can be synthesized through different methods, including enzymatic synthesis, chemical synthesis, and microbial fermentation. The synthesis of NMG involves the methylation of glycinamide, a reaction that can be catalyzed by various enzymes, such as N-methyltransferases.
NMG is known to possess various biological activities, including antimicrobial, antifungal, and anticancer properties. It has been shown to inhibit the growth of bacteria, fungi, and cancer cells in vitro and in vivo. NMG is also known to modulate the immune system, acting as an immunomodulatory agent.
NMG is studied for its potential therapeutic applications in various diseases, including cancer, infections, and autoimmune disorders. It has shown promise in treating cancer by inducing apoptosis and inhibiting tumor growth. NMG is also being investigated for its potential in treating infections by inhibiting the growth of pathogenic bacteria and fungi.
Furthermore, NMG is being studied for its potential applications in agriculture. It has been shown to promote plant growth and improve crop yields. NMG acts as a growth regulator and enhances the uptake of nutrients by plants.
The study of NMG is driven by its diverse biological activities and its potential applications in various fields, including medicine, agriculture, and industry. Understanding the synthesis, effects, and mechanisms of action of NMG is crucial for developing new drugs, pesticides, and other products. NMG holds significant promise as a therapeutic agent and a valuable tool for improving human health and agriculture.'
Cross-References
ID Source | ID |
PubMed CID | 89675 |
MeSH ID | M0119296 |
Synonyms (20)
Synonym |
BB 0254459 |
einecs 244-934-9 |
AKOS000118496 |
n-methylglycinamide |
2-amino-n-methylacetamide |
22356-89-4 |
2-amino-n-methyl-acetamide |
mfcd06375945 |
SY024913 |
UUYDPHCMCYSNAY-UHFFFAOYSA-N |
n1-methylglycinamide |
glycine methylamide |
DTXSID00176890 |
acetamide, 2-amino-n-methyl- |
2-amino-n-methyl-acetamide, aldrichcpr |
AS-58705 |
AC1534 |
FT-0719656 |
EN300-34309 |
CS-0008246 |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.32
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.32 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.40 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |